Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A W Partin

Showing results (51-60 of 234) with videos related to

Pageof 24
Sort By:
Urology|January 14, 1999
Influence of age and prostate-specific antigen on the chance of curable prostate cancer among men with nonpalpable diseaseH B Carter, J I Epstein, A W Partin
Urology|January 1, 1996
Ureteral bladder augmentation using the lower pole ureter of a duplicated systemJ Ben-Chaim, A W Partin, R D Jeffs
Seminars in Surgical Oncology|March 1, 1996
Role of laparoscopy in the diagnosis and treatment of prostate cancerR G Moore, A W Partin, L R Kavoussi
Reviews in Urology|September 21, 2006
Evaluation and treatment of men with biochemical prostate-specific antigen recurrence following definitive therapy for clinically localized prostate cancerC R Pound, M K Brawer, A W Partin
Urology|September 1, 1995
Can aggressive prostatic carcinomas be identified and can their natural history be altered by treatment?D M Quinlan, A W Partin, P C Walsh
Chromosoma|September 1, 1989
DNA loop domains in mammalian spermatozoaW S Ward, A W Partin, D S Coffey
Journal of Cellular Biochemistry. Supplement|June 5, 2001
Quantitative nuclear grade (QNG): a new image analysis-based biomarker of clinically relevant nuclear structure alterationsR W Veltri, A W Partin, M C Miller
Seminars in Urologic Oncology|September 19, 1998
Multivariate models as predictors of pathological stage using Gleason score, clinical stage, and serum prostate-specific antigenT J Polascik, J D Pearson, A W Partin
The Journal of Urology|June 7, 2000
Ability of the 1992 and 1997 American Joint Committee on Cancer staging systems for prostate cancer to predict progression-free survival after radical prostatectomy for stage T2 diseaseM Han, P C Walsh, A W Partin, et al.
The American Journal of Surgical Pathology|March 1, 1996
Prediction of progression following radical prostatectomy. A multivariate analysis of 721 men with long-term follow-upJ I Epstein, A W Partin, J Sauvageot, et al.
Pageof 24

Showing results (51-60 of 234) with videos related to

Sort By:
Pageof 24
Urology|January 14, 1999
Influence of age and prostate-specific antigen on the chance of curable prostate cancer among men with nonpalpable diseaseH B Carter, J I Epstein, A W Partin
Urology|January 1, 1996
Ureteral bladder augmentation using the lower pole ureter of a duplicated systemJ Ben-Chaim, A W Partin, R D Jeffs
Seminars in Surgical Oncology|March 1, 1996
Role of laparoscopy in the diagnosis and treatment of prostate cancerR G Moore, A W Partin, L R Kavoussi
Reviews in Urology|September 21, 2006
Evaluation and treatment of men with biochemical prostate-specific antigen recurrence following definitive therapy for clinically localized prostate cancerC R Pound, M K Brawer, A W Partin
Urology|September 1, 1995
Can aggressive prostatic carcinomas be identified and can their natural history be altered by treatment?D M Quinlan, A W Partin, P C Walsh
Chromosoma|September 1, 1989
DNA loop domains in mammalian spermatozoaW S Ward, A W Partin, D S Coffey
Journal of Cellular Biochemistry. Supplement|June 5, 2001
Quantitative nuclear grade (QNG): a new image analysis-based biomarker of clinically relevant nuclear structure alterationsR W Veltri, A W Partin, M C Miller
Seminars in Urologic Oncology|September 19, 1998
Multivariate models as predictors of pathological stage using Gleason score, clinical stage, and serum prostate-specific antigenT J Polascik, J D Pearson, A W Partin
The Journal of Urology|June 7, 2000
Ability of the 1992 and 1997 American Joint Committee on Cancer staging systems for prostate cancer to predict progression-free survival after radical prostatectomy for stage T2 diseaseM Han, P C Walsh, A W Partin, et al.
The American Journal of Surgical Pathology|March 1, 1996
Prediction of progression following radical prostatectomy. A multivariate analysis of 721 men with long-term follow-upJ I Epstein, A W Partin, J Sauvageot, et al.
Pageof 24